This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Russell, J. C. Articles by Bar-Tana, J. Search for Related Content PubMed PubMed Citation Articles by Russell, J. C. Articles by Bar-Tana, J. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Cardiomyopathy

(Arteriosclerosis, Thrombosis, and Vascular Biology. 1995;15:918-923.)
© 1995 American Heart Association, Inc.

Articles

Inhibition of Atherosclerosis and Myocardial Lesions in the JCR:LA-cp Rat by ß,ß'-Tetramethylhexadecanedioic Acid (MEDICA 16)

James C. Russell; Roger M. Amy; Sandra E. Graham; Peter J. Dolphin; George O. Wood; Jacob Bar-Tana

From the Departments of Surgery (J.C.R., S.E.G.) and Pathology (G.O.W.), University of Alberta, Edmonton; British Columbia Cancer Agency (R.M.A.), Vancouver; Department of Biochemistry (P.J.D.), Dalhousie University, Halifax, Nova Scotia, Canada; and Department of Human Nutrition and Metabolism (J.B.-T.), Hadassah Medical School, Hebrew University, Jerusalem, Israel.

Correspondence to Dr J.C. Russell, Department of Surgery, 275 Heritage Medical Research Centre, University of Alberta, Edmonton, Alberta T6G 2S2, Canada.

Abstract Atherosclerosis-prone, insulin-resistant JCR:LA-cp male rats were treated from 6 weeks to 39 weeks of age with ß,ß'-tetramethylhexadecanedioic acid (MEDICA 16). Body weights were reduced (13%, P<.001) at 36 weeks without any accompanying decrease in food consumption. The treatment did not cause any significant change in plasma glucose or fasting insulin concentrations. There was a significant decrease in the extreme hyperplasia of the islets of Langerhans (38%, P<.05). The marked VLDL hypertriglyceridemia was decreased by 70% (P<.001), with an accompanying significant reduction in cholesterol concentrations. The severity of raised atherosclerotic lesions on the aortic arch was very markedly reduced (P<.01) in treated rats. This was accompanied by a reduction (P<.01) in the incidence of ischemic myocardial lesions. We conclude that long-term (33 weeks) MEDICA 16 treatment of an animal model for the obesity/insulin-resistant/hyperlipidemic syndrome not only markedly improved lipid metabolism, but also inhibited the development of advanced cardiovascular disease.

Key Words: MEDICA 16 • myocardial lesions • hypertriglyceridemia • JCR:LA-cp rat • atherosclerosis

This article has been cited by other articles:

				J. C. Russell, S. D. Proctor, S. E. Kelly, and D. N. Brindley Pair feeding-mediated changes in metabolism: stress response and pathophysiology in insulin-resistant, atherosclerosis-prone JCR:LA-cp rats Am J Physiol Endocrinol Metab, June 1, 2008; 294(6): E1078 - E1087. [Abstract] [Full Text] [PDF]

				S. D. Proctor, K. L. Dreher, S. E. Kelly, and J. C. Russell Hypersensitivity of Prediabetic JCR:LA-cp Rats to Fine Airborne Combustion Particle-Induced Direct and Noradrenergic-Mediated Vascular Contraction Toxicol. Sci., April 1, 2006; 90(2): 385 - 391. [Abstract] [Full Text] [PDF]

				Z. Q. Wang, X. H. Zhang, J. C. Russell, M. Hulver, and W. T. Cefalu Chromium Picolinate Enhances Skeletal Muscle Cellular Insulin Signaling In Vivo in Obese, Insulin-Resistant JCR:LA-cp Rats J. Nutr., February 1, 2006; 136(2): 415 - 420. [Abstract] [Full Text] [PDF]

				C. T. Cramer, B. Goetz, K. L. M. Hopson, G. J. Fici, R. M. Ackermann, S. C. Brown, C. L. Bisgaier, W. G. Rajeswaran, D. C. Oniciu, and M. E. Pape Effects of a novel dual lipid synthesis inhibitor and its potential utility in treating dyslipidemia and metabolic syndrome J. Lipid Res., July 1, 2004; 45(7): 1289 - 1301. [Abstract] [Full Text] [PDF]

				L. L. Atkinson, R. Kozak, S. E. Kelly, A. Onay-Besikci, J. C. Russell, and G. D. Lopaschuk Potential mechanisms and consequences of cardiac triacylglycerol accumulation in insulin-resistant rats Am J Physiol Endocrinol Metab, May 1, 2003; 284(5): E923 - E930. [Abstract] [Full Text] [PDF]

				W. T. Cefalu, Z. Q. Wang, X. H. Zhang, L. C. Baldor, and J. C. Russell Oral Chromium Picolinate Improves Carbohydrate and Lipid Metabolism and Enhances Skeletal Muscle Glut-4 Translocation in Obese, Hyperinsulinemic (JCR-LA Corpulent) Rats J. Nutr., June 1, 2002; 132(6): 1107 - 1114. [Abstract] [Full Text] [PDF]

				S. J. Netherton, S. L. Jimmo, D. Palmer, D. G. Tilley, H. A. Dunkerley, D. R. Raymond, J. C. Russell, P. M. Absher, E. H. Sage, R. B. Vernon, et al. Altered Phosphodiesterase 3-Mediated cAMP Hydrolysis Contributes to a Hypermotile Phenotype in Obese JCR:LA-cp Rat Aortic Vascular Smooth Muscle Cells: Implications for Diabetes-Associated Cardiovascular Disease Diabetes, April 1, 2002; 51(4): 1194 - 1200. [Abstract] [Full Text] [PDF]

				M. Li, P. M. Absher, P. Liang, J. C. Russell, B. E. Sobel, and N. K. Fukagawa High Glucose Concentrations Induce Oxidative Damage to Mitochondrial DNA in Explanted Vascular Smooth Muscle Cells Experimental Biology and Medicine, May 1, 2001; 226(5): 450 - 457. [Abstract] [Full Text]

				J. C. Russell, D. Ravel, J.-P. Pégorier, P. Delrat, R. Jochemsen, S. F. O'Brien, S. E. Kelly, S. T. Davidge, and D. N. Brindley Beneficial Insulin-Sensitizing and Vascular Effects of S15261 in the Insulin-Resistant JCR:LA-cp Rat J. Pharmacol. Exp. Ther., November 1, 2000; 295(2): 753 - 760. [Abstract] [Full Text]

				F. Brunner, G. Wolkart, S. Pfeiffer, J. C Russell, and T. C Wascher Vascular dysfunction and myocardial contractility in the JCR:LA-corpulent rat Cardiovasc Res, July 1, 2000; 47(1): 150 - 158. [Abstract] [Full Text] [PDF]